Pediatric liver tumors - A pictorial review

European Radiology

Volumn 19, Issue 1, 2009, Pages 209-219

  Jha, Priyanka ^a   Chawla, Soni C ^b   Tavri, Sidhartha ^a   Patel, Chirag ^a   Gooding, Charles ^a   Daldrup Link, Heike ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

Author keywords

Adenoma; FNH; Hepatoblastoma; Hepatocellular carcinoma; Mesenchymal hamartoma; Pediatric liver tumors

Indexed keywords

ALPHA FETOPROTEIN; ENDOTHELIAL CELL GROWTH FACTOR;

ARTERIOVENOUS MALFORMATION; CELL FUNCTION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ECHOGRAPHY; HAMARTOMA; HEMANGIOENDOTHELIOMA; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; KUPFFER CELL; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER FOCAL NODULAR HYPERPLASIA; LIVER PARENCHYMA; LIVER SARCOMA; LIVER TUMOR; MESENCHYMAL HAMARTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SEX RATIO; UNDIFFERENTIATED EMBRYONAL SARCOMA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; INFANT; LIVER NEOPLASMS; MALE;

EID: 59249107909     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1106-7     Document Type: Review

References (43)

1. Kuhn JP, Slovis TL, Haller JO, Caffey J (eds) (2004) Caffey's pediatric diagnostic imaging, 10th edn. Mosby, Philadelphia
2. Helmberger TK, Ros PR, Mergo PJ et al (1999) Pediatric liver neoplasms: a radiologic-pathologic correlation. Eur Radiol 9:1339-1347
3. Emre S, McKenna GJ (2004) Liver tumors in children. Pediatr Transplant 8:632-638
4. Szymik-Kantorowicz S, Partyka L, Dembinska-Kiec A et al (2003) Vascular endothelial growth factor in monitoring therapy of hepatic haemangioendothelioma. Med Pediatr Oncol 40:196-197
5. Ayling RM, Davenport M, Hadzic N et al (2001) Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 138:932-935
6. Schneider G, Grazioli L, Saini S (eds) (2003) MRI of the liver: Imaging techniques, contrast enhancement, differential diagnosis. Springer, Milan, New York, p 214
7. Stringer MD, Alizai NK (2005) Mesenchymal hamartoma of the liver: A systematic review. J Pediatr Surg 40:1681-1690
8. Chang HJ, Jin SY, Park C et al (2006) Mesenchymal hamartomas of the liver: Comparison of clinicopathologic features between cystic and solid forms. J Korean Med Sci 21:63-68
9. Bartolotta TV, Midiri M, Galia M et al (2001) Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media. Radiol Med (Torino) 101:219-229
10. Beets-Tan RG, Van Engelshoven JM, Greve JW (1998) Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI. Clin Imaging 22:211-215
11. Kim MJ, Kim JH, Lim JS et al (2004) Detection and characterization of focal hepatic lesions: Mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging. J Magn Reson Imaging 20:612-621
12. Mergo PJ, Engelken JD, Helmberger T et al (1998) MRI in focal liver disease: A comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents. J Magn Reson Imaging 8:1073-1078
13. Urhahn R, Adam G, Busch N et al (1996) Superparamagnetic iron oxide particles: What value has the T1 effect in the MR diagnosis of focal liver lesions? Rofo 165:364-370
14. Pena CS, Saini S, Baron RL et al (2001) Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: Results of off-site blinded review in a phase-II multicenter trial. Korean J Radiol 2:210-215
15. Frohlich JM (2004) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): An intra-individual comparison. J Magn Reson Imaging 19:375-376 author reply 376
16. Grazioli L, Morana G, Kirchin MA et al (2003) MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): An intra-individual comparison. J Magn Reson Imaging 17:593-602
17. Maruyama K, Ikeda H, Koizumi T et al (2000) Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight. Pediatr Int 42:492-498
18. Tanimoto A, Kuwatsuru R, Kadoya M et al (1999) Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: Results from phase II and phase III clinical trials in Japan. J Magn Reson Imaging 10:450-460
19. Hamm B, Kirchin M, Pirovano G et al (1999) Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: Results of multicenter studies in Europe and the USA. J Comput Assist Tomogr 23(Suppl 1):S53-S60
20. Lauwers GY, Grant LD, Donnelly WH et al (1997) Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol 21:1248-1254
21. O'Sullivan MJ, Swanson PE, Knoll J et al (2001) Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: Report of a case and review of the literature. Pediatr Dev Pathol 4:482-489
22. Ramanujam TM, Ramesh JC, Goh DW et al (1999) Malignant transformation of mesenchymal hamartoma of the liver: Case report and review of the literature. J Pediatr Surg 34:1684-1686
23. Craig JR (1994) Mesenchymal tumors of the liver. Diagnostic problems for the surgical pathologist. Pathology (Phila) 3:141-160
24. Boechat MI, Kangarloo H (1989) MR imaging of the abdomen in children. AJR Am J Roentgenol 152:1245-1250
25. White KS (1996) Reduced need for sedation in patients undergoing helical CT of the chest and abdomen. Pediatr Radiol 26:5
26. Paterson A, Frush DP, Donnelly LF (2001) Helical CT of the body: Are settings adjusted for pediatric patients? AJR Am J Roentgenol 176:297-301
27. Frush DP, Slack CC, Hollingsworth CL et al (2002) Computer-simulated radiation dose reduction for abdominal multidetector CT of pediatric patients. AJR Am J Roentgenol 179:1107-1113
28. Slovis TL (2003) Children, computed tomography radiation dose, and the As Low As Reasonably Achievable (ALARA) concept. Pediatrics 112:971-972
29. da Costa e Silva EJ, da Silva GA (2007) Eliminating unenhanced CT when evaluating abdominal neoplasms in children. AJR Am J Roentgenol 189:1211-1214
30. Frush DP, Donnelly LF (1998) Helical CT in children: Technical considerations and body applications. Radiology 209:37-48
31. Vade A, Demos TC, Olson MC et al (1996) Evaluation of image quality using 1:1 pitch and 1.5:1Apitch helical CT in children: a comparative study. Pediatr Radiol 26:891
32. Vade A, Olson MC, Vittore CP et al (1999) Hepatic enhancement analysis in children using Smart Prep monitoring for 2:1 pitch helical scanning. Pediatr Radiol 29:689-693
33. Roche KJ, Genieser NB, Ambrosino MM (1996) Pediatric hepatic CT: An injection protocol. Pediatr Radiol 26:502-507
34. Ruess L, Bulas DI, Kushner DC et al (1998) Peak enhancement of the liver in children using power injection and helical CT. AJR Am J Roentgenol 170:677-681
35. Haliloglu M, Hoffer FA, Gronemeyer SA et al (2000) Three dimensional gadolinium-enhanced MR angiography evaluation of hepatic vasculature in children with hepatoblastoma. J Magn Reson Imaging 11
36. Teo EHJ, Strouse PJ, Prince MR (1999) Applications of magnetic resonance imaging and magnetic resonance angiography to evaluatge the hepatic vasculature in the pediatric patient. Pediatr Radiol 29:238-243
37. Rawsin JV, Seigel MJ (1996) Techniques and strategies in pediatric body MR imaging. Magn Reson Imaging Clin North Am 4:589-598
38. Gillies RJ, Morse DL (2005) In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 7:287-326
39. Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598-604
40. Li CW, Kuo YC, Chen CY et al (2005) Quantification of choline compounds in human hepatic tumors by proton MR spectroscopy at 3 T. Magn Reson Med 53:770-776
41. Weiner MW, Hetherington H, Hubesch B et al (1989) Clinical magnetic resonance spectroscopy of brain, heart, liver, kidney, and cancer. A quantitative approach. NMR Biomed 2:290-297
42. Bell JD, Bhakoo KK (1998) Metabolic changes underlying 31P MR spectral alterations in human hepatic tumours. NMR Biomed 11:354-359
43. Foley WD, Bree RL, Gay SB et al (2006) ACR Appropriateness Criteria for liver lesion characterization. American College of Radiology, Reston. Available via http://acsearch.acr.org/VariantList.aspx?topicid=30663. Accessed 31st March 2008